Pulmonary & Respiratory Research
Advancing COPD Clinical Research
Chronic Obstructive Pulmonary Disease (COPD) affects millions worldwide and remains a leading cause of respiratory complications and reduced quality of life. CenExel partners with sponsors to accelerate innovative COPD therapies through experienced pulmonary investigators, diverse patient populations, and high-quality clinical trial execution.
Studies Conducted
0
+
Trial Participants
0
+
Active Sites
0
+
Overview
Leading COPD Clinical Research
CenExel delivers specialized clinical research solutions for COPD and respiratory diseases. Our experienced investigators and operational teams support Phase I–IV pulmonary trials with a focus on patient safety, data quality, and accelerated enrollment.
Conditions Covered
COPD Conditions We Research
Our pulmonary research sites support a broad range of COPD-related and respiratory conditions, including chronic airway and inflammatory diseases.
- Chronic Obstructive Pulmonary Disease (COPD)
- Chronic Bronchitis
- Emphysema
- Asthma-COPD Overlap (ACO)
- Severe Asthma
- Pulmonary Inflammation
- Smoking-Related Lung Disease
- Respiratory Infections
Our Approach
Why Sponsors Choose CenExel for COPD
CenExel’s pulmonary research network combines scientific expertise, advanced respiratory assessments, and diverse patient populations to support successful COPD clinical trials.
01
Pulmonary Expertise
Experienced investigators specializing in COPD and chronic respiratory disease research.
02
Advanced Respiratory Testing
Sites equipped for spirometry, pulmonary function testing, and respiratory monitoring.
03
Diverse Patient Access
Broad access to COPD patient populations across multiple geographic regions.
04
High-Quality Trial Execution
From startup through closeout, our teams maintain operational excellence and data quality across every study phase.
Phase Coverage
Supported COPD Trial Phases
CenExel supports early and late-stage respiratory clinical trials — from proof-of-concept studies through Phase IV post-market pulmonary research.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our pulmonary research teams support biomarker analysis, respiratory endpoints, patient recruitment, and protocol execution with high-quality operational oversight.
Pulmonary Task Force
CenExel supports respiratory and pulmonary-focused clinical research across COPD, asthma, chronic bronchitis, emphysema, and related respiratory conditions through experienced investigators and specialized research sites.
Active Sites
18 Sites
CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg
